SecBot SecBot
144 ·Filed Nov 6, 2026

QURE

uniQure N.V.
NEUTRAL
Impact 2/10
Horizonimmediate Processed10d 9h ago SEC0001973379-26-000363
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine pre-planned sale under a 10b5-1 program; no immediate read-through for the stock. Monitor the company's next earnings release and pipeline updates for fundamental catalysts.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$22.79
T+0 close · Nov 6, 2026 · via day close
Latest settled
−3.99%
T+5 · $21.88
Vs SPY
−2.30%
α at T+5
Next horizon
T+20
in 21d
  1. T+0 · Nov 9 $22.79entry
  2. T+1 · 7d ago −0.35%α +0.02% · $22.71
  3. T+5 · 18h ago −3.99%α −2.30% · $21.88
  4. T+20 · in 21d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director David D. Meek filed a Form 144 notice of intent to sell 9,080 ordinary shares of uniQure N.V., valued at approximately $192,950. The sale is planned under a 10b5-1 trading plan adopted on May 26, 2026, and the shares were acquired through vested equity compensation. The filing is routine and represents a small fraction of the company's $1.6B market cap, with no material directional signal.

Key Facts

  • Director David D. Meek filed Form 144 to sell 9,080 ordinary shares
  • Estimated aggregate value of the proposed sale is $192,950
  • Sale is pursuant to a 10b5-1 plan adopted on May 26, 2026
  • Shares were acquired as vested equity compensation on November 6, 2026
  • The proposed sale represents less than 0.02% of uniQure's $1.6B market cap

Financial Impact

Proposed sale of 9,080 shares valued at $192,950, negligible relative to $1.6B market cap

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur or may differ in size and timing
  • No material risk identified from this filing alone

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001973379-26-000363
Document: 0001973379-26-000363-index.html0001973379-26-000363
Document: 0001973379-26-000363.txt0001973379-26-000363

Track record

38 reports on QURE

Performance horizon

6 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +27.15% at T+20 after the Jul 29, 2026 report. 8 of 11 went positive at some point.

Filters
  1. Nov 6, 202610d ago 144 Neutral 2/10 Viewing Entry $22.79 to $22.71 Now $21.88 −3.99% ▼ −0.35% +0.02% vs SPY
  2. Nov 4, 202612d ago 8-K Bullish 7/10 No price data
  3. Nov 4, 202612d ago Press Release Neutral 6/10 Entry $23.03 to $21.01 Now $21.88 −4.99% ▼ −8.77% −4.36% vs SPY
  4. Nov 2, 202614d ago 8-K Bullish 7/10 Entry $22.97 to $23.87 Now $21.88 −4.75% ▲ +3.92% +3.62% vs SPY
  5. Nov 2, 202614d ago Press Release Bullish 7/10 Entry $22.97 to $23.87 Now $21.88 −4.75% ▲ +3.92% +3.62% vs SPY
  6. Oct 16, 20264w ago SC 13G/A Neutral 3/10 Entry $21.78 to $22.20 Now $21.88 +0.46% ▲ +1.93% +1.51% vs SPY
  7. Sep 2, 202610w ago 8-K Bullish 7/10 Entry $46.23 to $44.86 Now $21.88 −52.67% ▼ −2.96% −4.01% vs SPY
  8. Jul 29, 202615w ago 8-K Bullish 8/10 Entry $40.07 to $42.19 Now $21.88 −45.40% ▲ +5.29% +3.61% vs SPY
  9. Jul 7, 202619w ago Insider Cluster Bearish 5/10 Entry $41.41 to $43.49 Now $21.88 +47.16% ▼ −5.02% −5.33% vs SPY
  10. Jul 2, 202619w ago Insider Cluster Bearish 4/10 Entry $41.81 to $41.36 Now $21.88 +47.67% ▲ +1.08% +1.95% vs SPY
Showing 10 of 38

US Market Status

Market Closed · Opens in 8h 2m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026